Drug Type Small molecule drug |
Synonyms Pivaloyloxymethylbutyrate, Pivanex, AN 9 + [1] |
Target |
Mechanism HDAC inhibitors(Histone deacetylase inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC10H18O4 |
InChIKeyGYKLFBYWXZYSOW-UHFFFAOYSA-N |
CAS Registry122110-53-6 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Chronic Lymphocytic Leukemia | Phase 2 | US | 01 May 2004 | |
Small Lymphocytic Lymphoma | Phase 2 | US | 01 May 2004 | |
Melanoma | Phase 2 | US | 01 Jan 2004 | |
Advanced Lung Non-Small Cell Carcinoma | Phase 2 | US | 01 Sep 2003 | |
Advanced Lung Non-Small Cell Carcinoma | Phase 2 | IN | 01 Sep 2003 | |
Advanced Lung Non-Small Cell Carcinoma | Phase 2 | GB | 01 Sep 2003 | |
Liver Cancer | Phase 2 | US | - | - |
Liver Cancer | Phase 2 | - | - | |
Liver Cancer | Phase 2 | - | - | |
Non-Small Cell Lung Cancer | Phase 2 | - | - |